Shilong Fu

ORCID: 0000-0001-7416-3070 · 4 papers in corpus
nonrandomized-trial 2010
Clinical outcomes of levonorgestrel-releasing intrauterine system in treating adenomyosis

Objective To evaluate the efficacy of levonorgestrel-releasing intrauterine system(LNG-IUS) in the treatment of adenomyosis.Methods LNG-IUS was inserted into uterine cavity in 44 women with adenomyosis.The patients were followed up for 12 m…

lab-animal 2009
Ectopic, autologous eutopic and normal endometrial stromal cells have altered expression and chemotactic activity of RANTES
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2008.12.001

OBJECTIVE: To evaluate if the expression and chemotactic activity of RANTES are different in IL-1beta treated autologous eutopic endometrial stromal cells compared to ectopic and normal endometrium. STUDY DESIGN: Conditioned media from IL-…

lab-animal 2009
ERB-041, a selective ER beta agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-kappaB activation
Molecular immunology ·doi:10.1016/j.molimm.2009.04.014

OBJECTIVE: The aim of the present study was to assess the anti-inflammatory effects of selective ER beta (ER beta) agonist on lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) production in peritoneal macrophages (PMs)…

lab-animal 2009
NF-kappaB decoy oligonucleotides suppress RANTES expression and monocyte chemotactic activity via NF-kappaB inactivation in stromal cells of ectopic endometrium
Journal of clinical immunology ·doi:10.1007/s10875-009-9274-z

BACKGROUND: The nuclear factor kappa B (NF-kappaB) pathway is a critical mediator of regulated on activation, normal T cell expressed and secreted (RANTES) gene regulation and therefore represents a potential target for therapy of endometri…